Pra health sciences, inc. (PRAH)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
Service revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,528,675

1,473,930

1,416,199

1,375,847

1,337,341

1,312,308

1,287,212

1,266,596

1,267,199

0

0

0

Reimbursement revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

239,597

244,597

239,329

238,036

217,559

216,419

206,212

192,990

201,639

0

0

0

Revenue

3,127,948

3,066,262

2,995,670

2,932,575

2,892,107

2,871,922

2,798,170

2,662,583

2,473,466

2,259,389

2,075,879

1,947,125

1,869,248

1,811,711

1,768,272

1,718,527

1,655,528

1,613,883

1,554,900

1,528,727

1,493,424

1,459,586

1,468,838

0

0

0

Operating expenses:
Selling, general and administrative expenses

404,787

394,925

387,812

384,823

377,188

371,795

367,641

354,395

339,421

321,987

300,015

287,898

280,171

269,893

263,234

259,135

249,572

246,417

256,520

256,861

253,966

253,970

250,011

0

0

0

Transaction-related costs

2,444

1,835

3,680

46,945

47,395

35,817

108,602

76,506

76,091

87,709

24,865

13,124

15,958

44,834

0

0

0

-

-

-

-

-

-

-

-

0

Depreciation and amortization expense

119,568

114,898

113,547

112,553

112,516

112,247

112,244

102,827

90,374

78,227

67,406

66,261

67,745

69,506

71,981

74,035

75,670

77,952

81,642

85,783

91,161

96,564

98,472

0

0

0

(Gain) loss on disposal of fixed assets, net

-951

-1,058

-998

-727

-222

-120

-139

-162

-262

-358

-703

-914

-807

-753

-546

-522

0

-

0

0

-

-

0

-

-

-

Income from operations

348,382

363,925

359,280

302,304

288,087

281,312

188,169

207,133

198,187

176,225

210,853

207,891

193,389

162,349

167,969

162,334

150,307

164,298

132,142

99,937

79,052

56,839

22,477

0

0

0

Interest expense, net

-53,105

-51,987

-51,373

-52,822

-54,943

-57,399

-59,501

-56,635

-52,027

-46,729

-43,476

-45,698

-49,074

-54,913

-58,208

-59,684

-61,720

-61,747

-64,393

-70,164

-75,566

-81,939

-87,313

0

0

0

Loss on modification or extinguishment of debt

-

-

0

-

-

-

0

-

-

-

0

-

-

-38,178

0

0

0

-

-

-

-

-25,036

-8,595

0

0

0

Foreign currency gains, net

-543

-2,257

2,238

-4,979

5,168

-1,043

-6,034

-17,019

-32,451

-39,622

-20,239

-6,263

19,565

24,029

14,515

17,030

2,192

14,048

17,776

24,737

23,316

10,538

-2,558

0

0

0

Other expense, net

258

174

-235

-318

-260

-371

-305

-232

-363

-304

-180

-290

0

-

0

0

-

-1,434

-3,528

-2,639

-2,659

-2,254

947

0

0

0

Income before income taxes

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest

-

-

307,557

243,233

-

221,547

109,941

118,224

98,323

74,547

127,848

139,744

147,654

93,894

102,779

97,216

68,324

115,165

58,345

28,219

491

-41,852

-75,042

0

0

0

Provision for income taxes

51,541

62,808

68,157

85,030

77,716

67,232

42,934

4,445

-2,852

-12,623

10,460

39,522

41,641

28,494

23,532

23,407

16,718

30,004

22,807

17,010

6,201

-8,154

-23,806

0

0

0

Income before equity in income of unconsolidated joint ventures

-

-

239,400

158,203

-

154,315

67,007

113,779

101,175

87,170

117,388

100,222

106,013

65,400

79,247

73,809

51,606

85,161

35,538

11,209

-5,710

-33,698

-51,236

0

0

0

Income (Loss) from Equity Method Investments

-

-

25

69

-

143

149

129

109

123

125

134

3,355

2,775

1,533

-819

-4,871

-3,396

-3,223

-1,378

-930

-2,044

-1,629

0

0

0

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

239,523

243,119

239,425

158,272

159,499

154,458

67,156

113,908

101,284

87,293

117,513

100,356

109,368

68,175

82,654

74,864

48,609

81,765

30,441

7,957

-8,514

-35,742

-52,865

0

0

0

Net income attributable to noncontrolling interest

-73

99

-246

113

491

553

751

793

600

366

513

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

Net income attributable to PRA Health Sciences, Inc.

239,596

243,020

239,671

158,159

159,008

153,905

66,405

113,115

100,684

86,927

134,424

124,889

0

-

0

0

-

-

-

-

-

-

-

-

-

-

Earnings Per Share [Abstract]
Basic (in dollars per share)

0.65

1.18

1.28

0.63

0.68

1.11

0.02

0.66

0.61

-0.26

0.77

0.47

0.41

0.23

0.52

0.64

-0.27

0.47

0.39

0.21

0.29

-0.51

0.03

-0.10

-0.25

-1.02

Diluted (in dollars per share)

0.63

1.15

1.25

0.62

0.66

1.07

0.02

0.64

0.59

-0.25

0.73

0.45

0.39

0.24

0.49

0.60

-0.27

0.45

0.37

0.20

0.27

-0.51

0.03

-0.10

-0.25

-1.02

Weighted average common shares outstanding:
Weighted Average Number of Shares Outstanding, Basic

62,933

62,733

64,771

65,328

65,192

64,827

64,261

63,874

63,530

63,208

62,730

62,232

61,578

61,303

60,937

60,597

60,199

60,124

60,050

59,871

59,815

50,768

40,284

40,268

40,268

39,337

Weighted Average Number of Shares Outstanding, Diluted

64,339

64,193

66,213

66,763

66,847

66,619

66,506

66,078

66,161

66,054

65,872

65,727

65,439

68,678

64,521

64,410

60,199

63,596

63,504

62,951

62,777

48,980

42,072

40,268

40,268

39,337

Direct Costs [Member]
Cost of revenues

1,565,515

1,539,541

1,519,158

1,501,276

1,496,682

1,500,226

1,503,389

1,458,832

1,377,788

1,283,868

1,189,343

1,122,388

1,076,713

1,032,688

993,215

946,113

911,054

886,528

866,589

869,527

863,028

859,218

867,051

0

0

0

Reimbursable expenses
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization

686,301

650,080

611,195

583,947

570,017

570,405

517,986

462,728

391,343

311,015

282,694

248,649

234,465

231,688

239,597

244,597

239,329

238,036

217,559

216,419

206,212

192,990

201,639

0

0

0

Reimbursable investigator fees
Cost of revenues

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-